Wellington Management Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Sell |
59,667
-14,194
| -19% | -$3.54M | ﹤0.01% | 1161 |
|
|
2025
Q4 | $17.8M | Buy |
73,861
+4,390
| +6% | +$1.12M | ﹤0.01% | 1077 |
|
|
2025
Q3 | $19M | Sell |
69,471
-7,597
| -10% | -$2.08M | ﹤0.01% | 1043 |
|
|
2025
Q2 | $19.9M | Buy |
77,068
+18,868
| +32% | +$4.5M | ﹤0.01% | 967 |
|
|
2025
Q1 | $13M | Buy |
58,200
+49,242
| +550% | +$11.5M | ﹤0.01% | 1127 |
|
|
2024
Q4 | $2.05M | Sell |
8,958
-50,968
| -85% | -$12.3M | ﹤0.01% | 1556 |
|
|
2024
Q3 | $14.6M | Buy |
59,926
+15,772
| +36% | +$3.52M | ﹤0.01% | 1062 |
|
|
2024
Q2 | $8.45M | Sell |
44,154
-1,584
| -3% | -$321K | ﹤0.01% | 1203 |
|
|
2024
Q1 | $9.06M | Buy |
45,738
+1,934
| +4% | +$354K | ﹤0.01% | 1167 |
|
|
2023
Q4 | $7.54M | Buy |
+43,804
| New | +$6.73M | ﹤0.01% | 1194 |
|
|
2023
Q3 | – | Sell |
-1,643
| Closed | -$359K | – | 1876 |
|
|
2023
Q2 | $359K | Sell |
1,643
-2,219
| -57% | -$495K | ﹤0.01% | 1720 |
|
|
2023
Q1 | $846K | Sell |
3,862
-188
| -5% | -$40.8K | ﹤0.01% | 1701 |
|
|
2022
Q4 | $843K | Buy |
+4,050
| New | +$890K | ﹤0.01% | 1679 |
|
|
2022
Q1 | – | Sell |
-2,780
| Closed | -$724K | – | 2203 |
|
|
2021
Q4 | $724K | Buy |
2,780
+1,966
| +242% | +$510K | ﹤0.01% | 1864 |
|
|
2021
Q3 | $214K | Sell |
814
-589
| -42% | -$161K | ﹤0.01% | 2101 |
|
|
2021
Q2 | $346K | Sell |
1,403
-2,232
| -61% | -$469K | ﹤0.01% | 1994 |
|
|
2021
Q1 | $705K | Buy |
3,635
+2,265
| +165% | +$454K | ﹤0.01% | 1786 |
|
|
2020
Q4 | $292K | Buy |
+1,370
| New | +$273K | ﹤0.01% | 1825 |
|
|
2020
Q2 | – | Sell |
-1,790
| Closed | -$264K | – | 1951 |
|
|
2020
Q1 | $264K | Buy |
1,790
+66
| +4% | +$10.5K | ﹤0.01% | 1824 |
|
|
2019
Q4 | $267K | Sell |
1,724
-437
| -20% | -$63K | ﹤0.01% | 1961 |
|
|
2019
Q3 | $292K | Buy |
+2,161
| New | +$283K | ﹤0.01% | 1954 |
|
|
2019
Q1 | – | Sell |
-14,450
| Closed | -$1.65M | – | 2103 |
|
|
2018
Q4 | $1.65M | Sell |
14,450
-47,151
| -77% | -$5.05M | ﹤0.01% | 1691 |
|
|
2018
Q3 | $7.11M | Buy |
61,601
+23,372
| +61% | +$2.56M | ﹤0.01% | 1379 |
|
|
2018
Q2 | $3.96M | Buy |
+38,229
| New | +$3.87M | ﹤0.01% | 1558 |
|
|
2017
Q1 | – | Sell |
-25,507
| Closed | -$1.58M | – | 2303 |
|
|
2016
Q4 | $1.58M | Buy |
25,507
+2,497
| +11% | +$153K | ﹤0.01% | 1756 |
|
|
2016
Q3 | $1.49M | Sell |
23,010
-1,256
| -5% | -$83.6K | ﹤0.01% | 1738 |
|
|
2016
Q2 | $1.53M | Buy |
24,266
+47
| +0.2% | +$2.77K | ﹤0.01% | 1671 |
|
|
2016
Q1 | $1.4M | Buy |
+24,219
| New | +$1.37M | ﹤0.01% | 1707 |
|
Other funds holding RMD
VCM
VPM
DAM
Wellington Management Group's RMD Position: Q1 2026 in Review
Wellington Management Group reduced its ResMed (RMD) stake by 19% in Q1 2026, selling an estimated $3.54M and leaving 59,667 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1161.
Wellington Management Group first reported a position in RMD in Q1 2016 and has held it in 28 quarters since. The position peaked at $19.9M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Wellington Management Group held 59,667 shares of ResMed worth $13.4M as of Q1 2026.
- Wellington Management Group sold 14,194 ResMed shares in Q1 2026, an estimated $3.54M.
- ResMed made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1161 holding.
- Wellington Management Group first reported a position in ResMed in Q1 2016 and has held it in 28 quarters since.
- Wellington Management Group's ResMed position peaked at $19.9M in Q2 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.